Photo by xteemu from unsplash
In this issue of Cancer Immunology Research, Ferris and colleagues demonstrate that type 1 conventional DC (cDC1) vaccines drive tumor rejection through direct antigen presentation, without the need of endogenous… Click to show full abstract
In this issue of Cancer Immunology Research, Ferris and colleagues demonstrate that type 1 conventional DC (cDC1) vaccines drive tumor rejection through direct antigen presentation, without the need of endogenous cDC1. This suggests that cDC1-based vaccines could represent an optimal strategy to induce antitumor immunity in patients. See related article by Ferris et al., (7).
Keywords:
cdc1;
cell presentation;
direct cell;
cancer;
immunology
Journal Title: Cancer immunology research
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer immunology research
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!